CS Diagnostics Corp. CSDX
0.01 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.07 Day range 0.07
0.0004 52-week range 0.40
- YTD
- -96.40%
- 1 year
- -96.56%
News
prismmediawire.com CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH Cheyenne, WY, February 11, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to…
globenewswire.com CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment…
prismmediawire.com CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products Cheyenne, WY, January 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – CS Diagnostics Corp.
globenewswire.com CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products CHEYENNE, Wyo., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), a medical technology and hygiene solutions company, today announced the confirmation of strategic manufacturing…
prismmediawire.com CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP Cheyenne, WY, January 21, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – CS Diagnostics Corp. (OTCQB: CSDX) today detailed its multi-channel sales strategy, global…
globenewswire.com CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP CHEYENNE, Wyo., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) today detailed its multi-channel sales strategy, global logistics partnerships, and sustainability roadmap…
accessnewswire.com CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering CHEYENNE, WYOMING / ACCESS Newswire / October 13, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) today announced the official launch of its Regulation D, Rule 506(c) investment offering (the "Offering"),…
accessnewswire.com CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering leader in innovative diagnostic and protective solutions, today…
accessnewswire.com CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market PARTNERING WITH PAUL & ALBRECHT PATENT LAWYERS CHEYENNE, WYOMING / ACCESS Newswire / September 8, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) is delighted to announce the submission of its CS-Protect…
accessnewswire.com CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC") NEUSS, GERMANY AND CHEYENNE, WY / ACCESS Newswire / July 16, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) is pleased to announce that it has successfully submitted the final draft of Form F-10…
globenewswire.com CS Diagnostics Corp. to Present at the Small Cap Growth Virtual Investor Conference June 26th DUBAI, United Arab Emirates, June 24, 2025 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX), based in Germany and USA and focused on innovation in Healthcare, today announced that Thomas…
accessnewswire.com CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor…
accessnewswire.com CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and…
accessnewswire.com OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS Innovative tissue spacer technology for cancer radiology treatments CHEYENNE, WY / ACCESS Newswire / March 12, 2025 / CS Diagnostics…